relapsed sarcoma
Showing 1 - 25 of 6,548
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)
Not yet recruiting
- Refractory Ewing Sarcoma
- +2 more
- (no location specified)
Feb 15, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CPI 613
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
May 10, 2023
Sarcoma, Ewing Trial in China (TK216+Vincristin)
Not yet recruiting
- Sarcoma, Ewing
- TK216+Vincristin
-
Beijing, Beijing, China
- +7 more
Jul 25, 2022
Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory
Active, not recruiting
- Metastatic Ewing Sarcoma
- +9 more
- Cabozantinib S-malate
- Laboratory Biomarker Analysis
-
Bordeaux, France
- +10 more
Nov 26, 2022
Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)
Not yet recruiting
- Sarcoma, Ewing
- Rhabdomyosarcoma
- PEN-866
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Sarcoma Trial in Turin (Autologous CIK)
Recruiting
- Sarcoma
- Autologous CIK
-
Turin, ItalyAOU Città della Salute e della Scienza di Torino - Presidio Infa
Aug 11, 2022
Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)
Recruiting
- Sarcoma, Clear Cell
- CPI-613 + Hydroxychloroquine
-
Duarte, California
- +7 more
Nov 10, 2022
Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)
Not yet recruiting
- Osteogenic Sarcoma Recurrent
-
Hackensack, New Jersey
- +1 more
Feb 3, 2023
Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab
Completed
- Tumor, Desmoplastic Small Round Cell, Adult
- +4 more
- nab paclitaxel
-
Barcelona, Spain
- +6 more
Jun 6, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan
Withdrawn
- Metastatic Ewing Sarcoma
- Recurrent Ewing Sarcoma
- Fine-Needle Aspiration
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,
Recruiting
- Relapsed Ewing Sarcoma
- +3 more
- Cabozantinib
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 27, 2021
Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)
Recruiting
- Neuroblastoma
- +5 more
- GD2-CART01
-
Roma, ItalyOspedale Pediatrico Bambino Gesù
Mar 9, 2022
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Soft Tissue Sarcoma, Retroperitoneal Sarcoma, Radiotherapy Side Effect Trial in Beijing (ultra-hypofractionated radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- +4 more
- ultra-hypofractionated radiotherapy
-
Beijing, Beijing, ChinaRadiotherapy Department of Cancer Hospital, Chinese Academy of M
Jan 25, 2022
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)
Active, not recruiting
- Ewing Sarcoma
- Ewing's Sarcoma Recurrent
-
Boston, Massachusetts
- +2 more
Mar 21, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023